Catálogo de publicaciones - libros
Título de Acceso Abierto
Oncolytic Virus Immunotherapy
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
oncolytic viruses; melanoma; immunotherapy; checkpoint inhibitors; combinatory therapy; reovirus; oncolytic virus; adenovirus; oncolytic; virotherapy; targeting; immunogenic cell death; αvβ6 integrin; oncolytic adenovirus; cancer immunotherapy; multi-stage; immunostimulatory; arming; HSV-1; clinical trials; newcastle disease virus; NDV; cancer; immune checkpoint inhibitor; PD-1; PD-L1; CTLA-4; type I interferon; herpes simplex virus; retargeted virus; tropism retargeting; tumor; checkpoint inhibitor; vaccination; antigen-agnostic vaccination; HER2; parvovirus; tumor microenvironment; combination therapy; glioblastoma; pancreatic cancer; colorectal cancer; measles virus; vector engineering; immune checkpoint blockade; antitumor immune response; delivery; genetic modification; biomarkers; personalized oncolyticvirotherapy; class I HLA; immunosurveillance; immunoediting; oncogenic signaling; RAS; DNA methyltransferase inhibitor (DNMTi); viral mimicry; epigenetic silencing; adoptive T cell therapy; CAR T cell; pancreatic ductal adenocarcinoma; vesicular stomatitis virus; small molecule; cancer immune therapy; cancer therapy; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-2548-8
País de edición
Suiza